BIOTECH ACQUISITION COMPANY Financing Cash Flow
BIOTECH ACQUISITION COMPANY reported Financing Cash Flow of $307.48 thousand for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2022-11-22
- BIOTECH ACQUISITION COMPANY net cash provided by (used in) financing activities for the quarter ending 2022-09-30 was $155.00K, a 17716.09% increase year-over-year.
- BIOTECH ACQUISITION COMPANY net cash provided by (used in) financing activities for the quarter ending 2022-06-30 was $37.50K, a 159.19% increase year-over-year.
- BIOTECH ACQUISITION COMPANY net cash provided by (used in) financing activities for the quarter ending 2022-03-31 was $114.98K, a 99.95% decline year-over-year.
- BIOTECH ACQUISITION COMPANY net cash provided by (used in) financing activities for the quarter ending 2021-12-31 was $0.00.
- BIOTECH ACQUISITION COMPANY net cash provided by (used in) financing activities for fiscal 2021 was $231.56M.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2022-09-30 | $155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-22 | $192.50K derived: sum of 2 quarters · filed 2022-11-22 | $307.48K 10-Q · filed 2022-11-22 | $307.48K derived: sum of 4 quarters · filed 2022-11-22 |
| 2022-06-30 | $37.50K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $152.48K 10-Q · filed 2022-08-22 | $152.48K derived: sum of 3 quarters · filed 2022-08-22 | $153.35K derived: sum of 4 quarters · filed 2022-11-22 |
| 2022-03-31 | $114.98K 10-Q · filed 2022-05-16 | $114.98K derived: sum of 2 quarters · filed 2022-05-16 | $115.85K derived: sum of 3 quarters · filed 2022-11-22 | $130.32K derived: sum of 4 quarters · filed 2022-11-22 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $870.00 derived: sum of 2 quarters · filed 2022-11-22 | $15.34K derived: sum of 3 quarters · filed 2022-11-22 | $231.56M 10-K · filed 2022-03-08 |
| 2021-09-30 | $870.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-22 | $15.34K derived: sum of 2 quarters · filed 2022-11-22 | $231.56M 10-Q · filed 2022-11-22 | |
| 2021-06-30 | $14.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $231.56M 10-Q · filed 2022-08-22 | ||
| 2021-03-31 | $231.54M 10-Q · filed 2022-05-16 |